Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2014
03/19/2014CN103648491A Methods and pharmaceutical compositions for inhibiting influenza viruses replication
03/19/2014CN103642898A Mutations in oas1 genes
03/19/2014CN103641892A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN103638524A Compound medicine for preventing and treating enteritis of poultry and preparation method thereof
03/19/2014CN103638523A Medicinal composition containing donepezil or its pharmaceutically acceptable salt and beta-receptor blocker
03/19/2014CN103638522A Methods of increasing lymphatic function
03/19/2014CN103638514A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN103637977A Drug-containing implants and methods of use thereof
03/19/2014CN103239723B Compound antihypertensive agent
03/19/2014CN102885784B Method for preparing microspheres by using oil-in-nanoparticle mixed suspension-nanometer medicament-in-oil
03/19/2014CN102697737B Tumor-targeting drug-loaded particles
03/19/2014CN102533868B Application of Lactobacillus casei LC2W in preparation of Alpha-glycosidase inhibitor
03/19/2014CN102333545B Enhanced migraine treatments based on ghrelin mimetics
03/19/2014CN102123712B Methods of cancer treatment with IGF1R inhibitors
03/19/2014CN101879166B Carbostyril derivative and serotonin reuptake inhibitor for treating patients with mood disorders
03/19/2014CN101252940B Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
03/18/2014US8674085 2′-branched nucleosides and Flaviviridae mutation
03/18/2014US8673964 Use of drug combinations for treating insulin resistance
03/18/2014US8673939 Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
03/18/2014US8673934 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
03/18/2014US8673903 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
03/18/2014US8673902 Method of treating otic infections with moxifloxacin compositions
03/18/2014US8673889 BLT2-mediated disease, BLT2 binding agent and the compound
03/18/2014US8673878 Mucosal treatment
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673366 Chemotherapeutic and prophylactic pharmaceutical compositions
03/18/2014US8673362 Therapeutic stem cell nutrient composition and uses thereof
03/18/2014US8673355 Opioid agonist/antagonist combinations
03/18/2014US8673343 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer
03/18/2014US8673321 Cyclophosphamide in combination with anti-idiotypic vaccines
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673296 Method and composition for producing a cellular allogeneic vaccine
03/18/2014US8673278 Bruise amelioration composition and method of use
03/18/2014CA2768682C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2405238C Single-dose antihistamine/decongestant formulations for treating rhinitis
03/18/2014CA2375633C Cranberry seed oil extract and compositions containing components thereof
03/13/2014WO2014039960A1 Methods for the treatment of locally advanced breast cancer
03/13/2014WO2014038623A1 3-(4-piperidyl)-indazole derivative
03/13/2014WO2014038622A1 Biomarker for autoimmune diseases
03/13/2014WO2014037532A1 Methods of treating alzheimer's disease and pharmaceutical compositions thereof
03/13/2014WO2014037121A1 Use of rifapentine in the treatment of tuberculosis in patients infected with the human immunodeficiency virus (hiv) / acquired immune deficiency syndrome (aids) and treated with an antiretroviral combination
03/13/2014WO2014012902A3 Melanosome transport inhibition for the treatment of melanoma
03/13/2014WO2013009521A9 Methods and compositions for treating asthma using anti-il-13 antibodies
03/13/2014US20140074181 Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
03/13/2014US20140073832 Anti-tumor t cell immunity induced by high dose radiation
03/13/2014US20140073691 Methods and composition for Treating Thyroid Hormone Related Disorders
03/13/2014US20140073690 Covalent inhibition of bacterial quorum sensing
03/13/2014US20140073679 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
03/13/2014US20140073677 Valsartan salts
03/13/2014US20140073669 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/13/2014US20140073666 Compositions and methods for treatment
03/13/2014US20140073664 Combination Dopamine Antagonist and Opiate Receptor Antagonist Treatment of Addictive Behavior
03/13/2014US20140073659 Treatment for vitiligo
03/13/2014US20140073653 Modulators of cystic fibrosis transmembrane conductance regulator
03/13/2014US20140073649 Isotopically enriched arylsulfonamide ccr3 antagonists
03/13/2014US20140073645 Treatment of Solid Tumours
03/13/2014US20140073640 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/13/2014US20140073637 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
03/13/2014US20140073634 Heterocyclic modulators of hif activity for treatment of disease
03/13/2014US20140073626 Azaindole derivatives as tyrosine kinase inhibitors
03/13/2014US20140073619 Method for treating chronic pain
03/13/2014US20140073613 Topical formulation for treatment of hyperkeratotic skin
03/13/2014US20140073610 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
03/13/2014US20140073606 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
03/13/2014US20140073593 Bruton's tyrosine kinase as anti-cancer drug target
03/13/2014US20140073590 Methods for Treating Pulmonary Hypertension
03/13/2014US20140073586 Compositions for the treatment of cancer, and methods for testing and using the same
03/13/2014US20140073584 Thienopyranones as Kinase Inhibitors
03/13/2014US20140073579 SMAC Mimetic
03/13/2014US20140073574 Therapy for complications of diabetes
03/13/2014US20140073571 Treatments for Gastrointestinal Disorders
03/13/2014US20140072657 Novel pharmaceutical formulation
03/13/2014US20140072647 Use of vanadium compounds for maintaining normaglycemia in a mammal
03/13/2014US20140072646 Thyroid hormone analogs and methods of use
03/13/2014US20140072638 Bone paste composition
03/13/2014US20140072637 Treatment for bone formation disorders by growth factor delivery
03/13/2014US20140072635 Thyroid hormone analogs and methods of use
03/13/2014US20140072631 Combinations and modes of administration of therapeutic agents and combination therapy
03/13/2014US20140072623 Gastric retained gabapentin dosage form
03/13/2014US20140072620 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/13/2014US20140072587 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
03/13/2014US20140072586 Antibody drug conjugates (adc) that bind to 158p1d7 proteins
03/13/2014US20140072583 Methods for treating atopic dermatitis by administering an il-4r antagonist
03/13/2014US20140072576 Chemokine receptor antagonists and use thereof
03/13/2014US20140072571 Osteoporosis associated markers and methods of use
03/13/2014US20140072570 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab
03/13/2014US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/13/2014US20140072555 Inhibitor Compounds and Cancer Treatment Methods
03/13/2014US20140072554 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
03/13/2014US20140072536 Methods of treating muscular dystrophy
03/13/2014US20140072532 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/13/2014US20140072529 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
03/13/2014US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/13/2014US20140069419 Isoxazolidine derivatives
03/12/2014EP2705855A1 Photodynamic therapy or diagnostic agent, using infrared-spectrum light
03/12/2014EP2705840A1 Use of rifapentine in the treatment and/or prevention of active tuberculosis disease
03/12/2014EP2705836A1 Pharmaceutical compositions having desirable bioavailability
03/12/2014EP2704728A1 Expression signatures of genes and gene networks associated with skin aging
03/12/2014EP2704713A1 Csf-1r inhibitors for treatment of brain tumors
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1151